CEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...

Moderna's first-quarter revenue surpassed estimates, driven by strong international COVID-19 vaccine sales. The company forecasts lower-tha...

Moderna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.

Moderna and Merck said on Tuesday their ⁠experimental personalized vaccine continued to cut the risk of death or recurrence of the most dea...

A top U.S. health official called for breaking up the combined MMR vaccine, a move quickly opposed by Merck, which cited a lack of scientif...

Moderna has delayed its break-even goal by two years, pushing it to 2028, due to slower regulatory processes for key products like flu and ...

Russian President Vladimir Putin announced that Russian scientists are close to developing cancer vaccines, potentially revolutionizing can...

China may soon find it difficult to source semiconductors specific to the development of artificial intelligence, expanding on US export co...

Decades before Covid vaccines, scientists had been working on messenger ribonucleic acid (mRNA) vaccines targeting cancer.

Data revealed that using Merck's immunotherapy drug in combination with high-risk patients decreased their risk of dying.

Stocks have been making their moves recently, such as Starbucks, SoFi, Nucor, CSX, and more. Here are the details of them.

The deal, announced on Tuesday, is the biggest in the sector so far this year and ends a dearth of large acquisitions, which along with cli...

The recommendations have been sent to the Drug Controller General of India (DCGI), which will soon decide on their approval, people in the ...

The first pill to treat Covid-19 is on its way and vaccine producers are rolling out booster shots in wealthy countries. For investors, the...

Biden said the increasing availability of vaccinations was making a difference in containing the pandemic, but it was critical to remain vi...

The drugmaker said Monday that it will focus instead on studying two possible treatments for the virus that also have yet to be approved by...

Novel cancer drugs often come with six-figure price tags, so success could be lucrative. Numerous companies are chasing a cancer vaccine. O...